文献速递头颈神经CT

治疗前双能CT预测鼻咽癌诱导化疗早期反应及生存

Pretreatment dual-energy CT for predicting early response to induction chemotherapy and survival in nasopharyngeal carcinoma.
PubMed 文献 · Eur Radiol · 2023-07-05

回顾性纳入56例鼻咽癌患者,治疗前双能CT测得肿瘤病灶的标准化碘浓度(nIC)和有效原子序数(Zeff)可预测诱导化疗早期客观反应及生存;高nIC值是生存不良的独立预测因素。

要点

  • 治疗前双能CT的nIC和Zeff可预测鼻咽癌诱导化疗早期客观反应及生存。
  • 高nIC值是鼻咽癌生存不良的独立预测因素。
  • nIC值较高的鼻咽癌患者5年无局部区域失败生存率、无进展生存率和总生存率倾向于较低。

核心结论

  • 双能CT衍生的nIC和Zeff值可预测鼻咽癌诱导化疗早期反应及生存,高nIC值是生存不良的独立预测因素。

研究设计与样本

  • 回顾性研究,纳入56例接受治疗前双能CT扫描并有治疗后随访的鼻咽癌患者。

诊断标准与关键数值

  • nIC预测早期客观反应的AUC为0.803,Zeff为0.826;nIC预测无局部区域失败生存的AUC为0.786,Zeff为0.767;nIC预测无进展生存的AUC为0.856,Zeff为0.731;nIC预测总生存的AUC为0.765,Zeff为0.799(均p<0.05)。

临床应用与阅片要点

  • 治疗前双能CT可能为鼻咽癌患者的早期反应和生存结局提供预测价值,并有助于其临床管理。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate the predictive performance of pretreatment dual-energy CT (DECT) for early response to induction chemotherapy and survival in nasopharyngeal carcinoma (NPC).

METHODS: In this retrospective study, 56 NPC patients who underwent pretreatment DECT scans with posttreatment follow-up were enrolled. The DECT-derived normalised iodine concentration (nIC), effective atomic number (Zeff), 40-180 keV (20 keV interval), and Mix-0.3 value of the tumour lesions were measured to predict the early response to induction chemotherapy and survival in nasopharyngeal carcinoma. The Mann‒Whitney U test, ROC analysis, Kaplan‒Meier method with log-rank test, and Cox proportional hazards model were performed to evaluate the predictive performance of DECT parameters, respectively.

RESULTS: Among all DECT-derived parameters, ROC analysis showed the predictive performances of nIC and Zeff values for early objective response to induction chemotherapy (AUCs of 0.803 and 0.826), locoregional failure-free survival (AUCs of 0.786 and 0.767), progression-free survival (AUCs of 0.856 and 0.731) and overall survival (AUCs of 0.765 and 0.799) in NPC patients, respectively (all p < 0.05). Moreover, multivariate analysis showed that a high nIC value was an independent predictor of poor survival in NPC. In addition, survival analysis indicated that NPC patients with higher nIC values in primary tumours tend to have lower 5-year locoregional failure-free survival, progression-free survival and overall survival rates than those with lower nIC values.

CONCLUSIONS: DECT-derived nIC and Zeff values can predict early response to induction chemotherapy and survival in NPC; in particular, a high nIC value is an independent predictive factor of poor survival in NPC.

CLINICAL RELEVANCE STATEMENT: Preoperative dual-energy computed tomography may provide predictive value for early response and survival outcomes in patients with nasopharyngeal carcinoma, and facilitate their clinical management.

KEY POINTS: • Pretreatment dual-energy computed tomography helps to predict early response to therapy and survival in NPC. • NIC and Zeff values derived from dual-energy computed tomography can predict early objective response to induction chemotherapy and survival in NPC. • A high nIC value is an independent predictive factor of poor survival in NPC.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Zhan, Wang, Wang, et al. Pretreatment dual-energy CT for predicting early response to induction chemotherapy and survival in nasopharyngeal carcinoma. Eur Radiol. 2023. PMID: 37405505. doi:10.1007/s00330-023-09837-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。